The Human Papillomavirus and Its Role in Plantar Warts

A Comprehensive Review of Diagnosis and Management
Published:March 29, 2016DOI:https://doi.org/10.1016/j.cpm.2016.02.003

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Podiatric Medicine and Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Vlahovic T.C.
        • Schleicher S.M.
        Skin disease of the lower extremities: a photographic guide.
        HMP Communications, 2012
        • Sterling J.C.
        • Handfield-Jones S.
        • Hudson P.M.
        • British Association of Dermatologists
        Guidelines for management of cutaneous warts.
        Br J Dermatol. 2001; 144: 4-11
        • de Koning M.N.
        • ter Schegget J.
        • Eekhof J.A.
        • et al.
        Evaluation of a novel broad-spectrum PCR-multiplex genotyping assay for identification of cutaneous wart-associated human papillomavirus types.
        J Clin Microbiol. 2010; 48: 1706-1711
        • de Villiers E.M.
        • Fauquet C.
        • Broker T.R.
        • et al.
        Classification of papillomaviruses.
        Virology. 2004; 324: 17-27
        • Chan S.Y.
        • Chew S.H.
        • Egawa K.
        • et al.
        Phylogenetic analysis of the human papillomavirus type 2 (HPV-2), HPV-27, and HPV-57 group, which is associated with common warts.
        Virology. 1997; 239: 296-302
        • Gassenmaier A.
        • Fuchs P.
        • Schell H.
        • et al.
        Papillomavirus DNA in warts of immunosuppressed renal allograft recipients.
        Arch Dermatol Res. 1986; 278: 219-223
        • Hagiwara K.
        • Uezato H.
        • Arakaki H.
        • et al.
        A genotype distribution of human papillomaviruses detected by polymerase chain reaction and direct sequencing analysis in a large sample of common warts in Japan.
        J Med Virol. 2005; 77: 107-112
        • Harwood C.A.
        • Spink P.J.
        • Surentheran T.
        • et al.
        Degenerate and nested PCR: a highly sensitive and specific method for detection of human papillomavirus infection in cutaneous warts.
        J Clin Microbiol. 1999; 37: 3545-3555
        • Lai J.Y.
        • Doyle R.J.
        • Bluhm J.M.
        • et al.
        Multiplexed PCR genotyping of HPVs from plantaris verrucae.
        J Clin Virol. 2006; 35: 435-441
        • Pfister H.
        Chapter 8: human papillomavirus and skin cancer.
        J Natl Cancer Inst Monogr. 2003; 31: 52-56
        • Porro A.M.
        • Alchorne M.M.
        • Mota G.R.
        • et al.
        Detection and typing of human papillomavirus in cutaneous warts of patients infected with human immunodeficiency virus type 1.
        Br J Dermatol. 2003; 149: 1192-1199
        • Rübben A.
        • Kalka K.
        • Spelten B.
        • et al.
        Clinical features and age distribution of patients with HPV 2/27/57-induced common warts.
        Arch Dermatol Res. 1997; 289: 337-340
        • Rübben A.
        • Krones R.
        • Schwetschenau R.
        • et al.
        Common warts from immunocompetent patients show the same distribution of human papillomavirus types as common warts from immunocompromised patients.
        Br J Dermatol. 1993; 128: 264-270
        • Chen S.L.
        • Tsao Y.P.
        • Lee J.W.
        • et al.
        Characterization and analysis of human papillomaviruses of skin warts.
        Arch Dermatol Res. 1993; 285: 460-465
        • Egawa K.
        • Delius H.
        • Matsukura T.
        • et al.
        Two novel types of human papillomavirus, HPV 63 and HPV 65: comparisons of their clinical and histological features and DNA sequences to other HPV types.
        Virology. 1993; 194: 789-799
        • Grimmel M.
        • de Villiers E.M.
        • Neumann C.
        • et al.
        Characterization of a new human papillomavirus (HPV 41) from disseminated warts and detection of its DNA in some skin carcinomas.
        Int J Cancer. 1988; 41: 5-9
        • Euvrard S.
        • Kanitakis J.
        • Claudy A.
        Skin cancers after organ transplantation.
        N Engl J Med. 2003; 348: 1681-1691
        • Ulrich C.
        • Hackethal M.
        • Meyer T.
        • et al.
        Skin infections in organ transplant recipients.
        J Dtsch Dermatol Ges. 2008; 6: 98-105
        • van Haalen F.M.
        • Bruggink S.C.
        • Gussekloo J.
        • et al.
        Warts in primary schoolchildren: prevalence and relation with environmental factors.
        Br J Dermatol. 2009; 161: 148-152
        • Bouwes Bavinck J.N.
        • Euvrard S.
        • Naldi L.
        • et al.
        Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy.
        J Invest Dermatol. 2007; 127: 1647-1656
        • Egawa K.
        • Honda Y.
        • Inaba Y.
        • et al.
        Pigmented viral warts: a clinical and histopathological study including human papillomavirus typing.
        Br J Dermatol. 1998; 138: 381-389
        • Egawa K.
        New types of human papillomaviruses and intracytoplasmic inclusion bodies: a classification of inclusion warts according to clinical features, histology and associated HPV types.
        Br J Dermatol. 1994; 130: 158-166
        • Phillips A.C.
        • Vousden K.H.
        Analysis of the interaction between human papillomavirus type 16 E7 and the TATA binding protein TBP.
        J Gen Virol. 1997; 78: 905-909
        • Bernard H.U.
        Controls in the papillomavirus life cycle.
        FEMS Microbiol Immunol. 1990; 2: 201-205
        • Lipke M.M.
        An armamentarium of wart treatments.
        Clin Med Res. 2006; 4: 273-293
        • Thappa D.M.
        The isomorphic phenomenon of Koebner.
        Indian J Dermatol Venereol Leprol. 2004; 70 (Available at:) (Accessed November 30, 2015): 187-189
        • Gibbs S.
        • Harvey I.
        • Sterling J.C.
        • et al.
        Local treatments for cutaneous warts.
        Cochrane Database Syst Rev. 2003; (CD001781)
        • Gupta R.
        • Gupta S.
        Topical adapalene in the treatment of plantar warts; randomized comparative open trial in comparison with cryo-therapy.
        Indian J Dermatol. 2015; 60: 102
        • Salk R.S.
        • Grogan K.A.
        • Chang T.J.
        Topical 5% 5-fluorouracil cream in the treatment of plantar warts: a prospective, randomized, and controlled clinical study.
        J Drugs Dermatol. 2006; 5: 418-424
        • Mullen B.R.
        • Guiliana J.V.
        • Nesheiwat F.
        Cimetidine as a first-line therapy for pedal verruca.
        J Am Podiatr Med Assoc. 2005; 95: 229-234
        • Focht 3rd, D.R.
        • Spicer C.
        • Fairchok M.P.
        The efficacy of duct tape vs cryotherapy in the treatment of verruca vulgaris (the common wart).
        Arch Pediatr Adolesc Med. 2002; 156: 971-974
        • Soni P.
        • Khandelwal K.
        • Aara N.
        • et al.
        Efficacy of intralesional bleomycin in palmo-plantar and periungual warts.
        J Cutan Aesthet Surg. 2011; 4: 188-191
        • Munn S.E.
        • Higgins E.
        • Marshall M.
        • et al.
        A new method of intralesional bleomycin therapy in the treatment of recalcitrant warts.
        Br J Dermatol. 1996; 135: 969-971
        • Signore R.J.
        Candida albicans intralesional injection immunotherapy of warts.
        Cutis. 2002; 70: 185
        • Clifton M.M.
        • Johnson S.M.
        • Roberson P.K.
        • et al.
        Immunotherapy for recalcitrant warts in children using intralesional mumps or Candida antigens.
        Pediatr Dermatol. 2003; 20: 268
        • Vlahovic T.C.
        • Spadone S.
        • Dunn S.P.
        • et al.
        Candida albicans immunotherapy for verrucae plantaris.
        J Am Podiatr Med Assoc. 2015; 105: 395-400
        • Davidson L.
        Marigold rediscovered: a cure for callosities.
        Therapy. 1980; : 1
        • Khan Jr., M.T.
        Tagetes signata in the treatment of verruca pedis.
        J British Pod Med. 1996; 51: 118b
        • Khan M.T.
        • Khan M.T.
        A double blind placebo study of topical Tagetes on verruca pedis in children and adults.
        J Eur Acad Dermatol Venereol. 1999; 1: S251
        • Khan M.T.
        • Cerio R.
        • Khan Sr., M.T.
        The efficacy of Thuja occidentalis on verruca pedis in children and adults.
        J Eur Acad Dermatol Venereol. 1998; 11: S150
        • Khan M.T.
        • Cerio R.
        • Watt R.
        • et al.
        A double blind placebo study of topical Thuja occidentalis on verruca pedis in children and adults.
        J Eur Acad Dermatol Venereol. 1999; 1: S251
      1. Available at: http://healthland.time.com/2011/02/03/gardasil-protects-boys-and-men-from-hpv-too/. Accessed March 18, 2016.

        • Venugopal S.S.
        • Murrell D.F.
        Recalcitrant cutaneous warts treated with recombinant quadrivalent human papillomavirus vaccine (types 6, 11, 16, and 18) in a developmentally delayed, 31-year-old white man.
        Arch Dermatol. 2010; 146: 475-477
        • Kreuter A.
        • Waterboer T.
        • Wieland U.
        Regression of cutaneous warts in a patient with WILD syndrome following recombinant quadrivalent human papillomavirus vaccination.
        Arch Dermatol. 2010; 146: 1196-1197
        • Pringle W.M.
        • Helms D.C.
        Treatment of plantar warts by blunt dissection.
        Arch Dermatol. 1973; 108: 79-82
        • Ault K.A.
        Human papillomavirus vaccines and the potential for cross-protection between related HPV types.
        Gynecol Oncol. 2007; 107: S31-S33
        • Daniel B.S.
        • Murrell D.F.
        Complete resolution of chronic multiple verruca vulgaris treated with quadrivalent human papillomavirus vaccine.
        JAMA Dermatol. 2013; 149: 370-372
        • Serour F.
        • Somekh E.
        Successful treatment of recalcitrant warts in pediatric patients with carbon dioxide laser.
        Eur J Pediatr Surg. 2003; 13: 219-223
        • Gloster H.M.
        • Roenigk R.
        Risk of acquiring human papillomavirus from the plume produced by the carbon dioxide laser in the treatment of warts.
        J Am Acad Dermatol. 1995; 32: 436-441
        • Zeng Y.
        • Zheng Y.
        • Wang L.
        Vagarious successful treatment of recalcitrant warts in combination with CO2 laser and imiquimod 5% cream.
        J Cosmet Laser Ther. 2014; 16: 311-313
        • Patil U.A.
        • Dhami L.D.
        Overview of lasers.
        Indian J Plast Surg. 2008; 41: S101-S113
        • El-Mohamady Ael-S.
        • Mearag I.
        • El-Khalawany M.
        • et al.
        Pulsed dye laser versus Nd:YAG laser in the treatment of plantar warts: a comparative study.
        Lasers Med Sci. 2014; 29: 1111-1116
        • Baruch K.
        Blunt dissection for the treatment of plantar verrucae.
        Cutis. 1990; 46 (151-2): 145-147
        • Leman J.A.
        • Benton E.C.
        Verrucas. Guidelines for management.
        Am J Clin Dermatol. 2000; 1: 143-149
        • Arndt K.A.
        • Bowers K.E.
        • Alam M.
        • et al.
        Warts.
        in: Manual of dermatologic therapeutics. 6th edition. Lippincott Williams & Wilkins, Philadelphia2002: 241-251